Survey to Evaluate the Effectiveness of Risk Minimisation Measures for Atezolizumab Use in the European Union

07/12/2017
02/07/2024
EU PAS number:
EUPAS21920
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

Physicians survey
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No